Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
12.85
-0.34 (-2.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Apollomics Market Cap
Apollomics has a market cap or net worth of $27.59 million as of April 28, 2026. Its market cap has increased by 231.41% in one year.
Market Cap
27.59M
Enterprise Value
24.85M
1-Year Change
231.41%
Ranking
Category
Stock Price
$12.85
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $27.59M, a decrease of -78.71%. That is a compound annual growth rate of -29.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 28.32M | -29.42% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 29.08M |
| Lisata Therapeutics | 28.90M |
| Kyntra Bio | 28.89M |
| BriaCell Therapeutics | 28.09M |
| Polyrizon | 27.74M |
| Lantern Pharma | 27.57M |
| Longeveron | 27.52M |
| NanoViricides | 27.21M |